Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Cypress Bioscience expands Prosorba Column pilot program

Aug. 9, 2000

New sPLA2 inhibitors under development at Lilly

Aug. 4, 2000

JNK protein kinase inhibitors under study at Roche

Aug. 3, 2000

Research links autoantibodies to the symptoms of Sjogren's syndrome

Aug. 3, 2000

Licensing opportunity from NIH: TNF receptor domain

Aug. 2, 2000

Roche presents new inhibitors of TNF-alpha release and their potential uses

July 31, 2000

TNF-alpha inhibitors and use in therapy of joint inflammation, asthma

July 28, 2000

Specific inhibitors of COX-2 reported by Ortho-McNeil

July 27, 2000

Preparation, activity and use of ICE inhibitors disclosed by Warner-Lambert (Pfizer)

July 27, 2000

Clinical trials continue to support the utility of Merck's new coxib MK-0663

July 26, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...